| Radiotherapy induces responses of lung cancer to CTLA-4 blockade SC Formenti, NP Rudqvist, E Golden, B Cooper, E Wennerberg, ... Nature medicine 24 (12), 1845-1851, 2018 | 821 | 2018 |
| Radiotherapy and CTLA-4 blockade shape the TCR repertoire of tumor-infiltrating T cells NP Rudqvist, KA Pilones, C Lhuillier, E Wennerberg, JW Sidhom, ... Cancer immunology research 6 (2), 139-150, 2018 | 213 | 2018 |
| Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms Y Mao, I Poschke, E Wennerberg, Y Pico de Coaña, S Egyhazi Brage, ... Cancer research 73 (13), 3877-3887, 2013 | 197 | 2013 |
| CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo E Wennerberg, V Kremer, R Childs, A Lundqvist Cancer immunology, immunotherapy 64, 225-235, 2015 | 189 | 2015 |
| In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment C Vanpouille-Box, KA Pilones, E Wennerberg, SC Formenti, S Demaria Vaccine 33 (51), 7415-7422, 2015 | 187 | 2015 |
| Barriers to Radiation-Induced In Situ Tumor Vaccination E Wennerberg, C Lhuillier, C Vanpouille-Box, KA Pilones, ... Frontiers in Immunology 8, 229, 2017 | 185 | 2017 |
| IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells Y Mao, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, L Masvidal, ... Blood, The Journal of the American Society of Hematology 128 (11), 1475-1489, 2016 | 172 | 2016 |
| Exercise in regulation of inflammation-immune axis function in cancer initiation and progression GJ Koelwyn, E Wennerberg, S Demaria, LW Jones Oncology (Williston Park, NY) 29 (12), 2015 | 157 | 2015 |
| Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma V Kremer, MA Ligtenberg, R Zendehdel, C Seitz, A Duivenvoorden, ... Journal for immunotherapy of cancer 5, 1-13, 2017 | 156 | 2017 |
| Exercise reduces immune suppression and breast cancer progression in a preclinical model E Wennerberg, C Lhuillier, MD Rybstein, K Dannenberg, NP Rudqvist, ... Oncotarget 11 (4), 452, 2020 | 120 | 2020 |
| CD73 blockade promotes dendritic cell infiltration of irradiated tumors and tumor rejection E Wennerberg, S Spada, NP Rudqvist, C Lhuillier, S Gruber, Q Chen, ... Cancer immunology research 8 (4), 465-478, 2020 | 115 | 2020 |
| Immune recognition of irradiated cancer cells E Wennerberg, C Vanpouille‐Box, S Bornstein, T Yamazaki, S Demaria, ... Immunological reviews 280 (1), 220-230, 2017 | 87 | 2017 |
| Doxorubicin sensitizes human tumor cells to NK cell‐and T‐cell‐mediated killing by augmented TRAIL receptor signaling E Wennerberg, D Sarhan, M Carlsten, VO Kaminskyy, P D'Arcy, ... International journal of cancer 133 (7), 1643-1652, 2013 | 76 | 2013 |
| HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines R Okita, D Mougiakakos, T Ando, Y Mao, D Sarhan, E Wennerberg, ... The Journal of Immunology 188 (5), 2136-2145, 2012 | 75 | 2012 |
| Hallmarks of resistance to immune-checkpoint inhibitors M Karasarides, AP Cogdill, PB Robbins, M Bowden, EM Burton, ... Cancer Immunology Research 10 (4), 372-383, 2022 | 67 | 2022 |
| Human anaplastic thyroid carcinoma cells are sensitive to NK cell–mediated lysis via ULBP2/5/6 and chemoattract NK cells E Wennerberg, A Pfefferle, L Ekblad, Y Yoshimoto, V Kremer, ... Clinical Cancer Research 20 (22), 5733-5744, 2014 | 61 | 2014 |
| Gap junction intercellular communications regulate NK cell activation and modulate NK cytotoxic capacity A Tittarelli, A Mendoza-Naranjo, M Farías, I Guerrero, F Ihara, ... The Journal of Immunology 192 (3), 1313-1319, 2014 | 59 | 2014 |
| Targeting cancer heterogeneity with immune responses driven by oncolytic peptides I Vitale, T Yamazaki, E Wennerberg, B Sveinbjørnsson, Ø Rekdal, ... Trends in Cancer 7 (6), 557-572, 2021 | 53 | 2021 |
| Kickstarting immunity in cold tumours: localised tumour therapy combinations with immune checkpoint blockade E Appleton, J Hassan, C Chan Wah Hak, N Sivamanoharan, A Wilkins, ... Frontiers in Immunology 12, 754436, 2021 | 42 | 2021 |
| A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells D Sarhan, E Wennerberg, P D’Arcy, D Gurajada, S Linder, A Lundqvist Cancer Immunology, Immunotherapy 62, 1359-1368, 2013 | 40 | 2013 |
Andreas LundqvistAssociate Professor, Karolinska Institutet Verified email at ki.se
